Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MMP25 |
| Upstream (Parents) |
|---|
| (<<) ACTN4 → MMP25 |
| (<<) ADAM19 → MMP25 |
| (<<) CASP9 → MMP25 |
| (<<) DDX21 → MMP25 |
| (<<) DNAJA4 → MMP25 |
| (<<) DSCAM → MMP25 |
| (<<) GRK5 → MMP25 |
| (<<) ITGA2 → MMP25 |
| (<<) MAP2K3 → MMP25 |
| (<<) MAP3K7 → MMP25 |
| (<<) MAP3K8 → MMP25 |
| (<<) PIK3C3 → MMP25 |
| (<<) PIK3R5 → MMP25 |
| (<<) S100A2 → MMP25 |
| (<<) SHC1 → MMP25 |
| (<<) SMAD5 → MMP25 |
| (<<) SPPL2B → MMP25 |
| (<<) SPR → MMP25 |
| (<<) SPRR1B → MMP25 |
| (<<) STK4 → MMP25 |
| (<<) SYK → MMP25 |
| (<<) TGFA → MMP25 |
| Downstream (Children) |
|---|
| MMP25 → ADORA2B (>>) |
| MMP25 → ASB1 (>>) |
| MMP25 → ATP2B4 (>>) |
| MMP25 → CCNL1 (>>) |
| MMP25 → CDH22 (>>) |
| MMP25 → CLCA4 (>>) |
| MMP25 → DHX9 (>>) |
| MMP25 → DMPK (>>) |
| MMP25 → DUSP1 (>>) |
| MMP25 → DUSP7 (>>) |
| MMP25 → EPHA4 (>>) |
| MMP25 → FOXO3 (>>) |
| MMP25 → IL1A (>>) |
| MMP25 → ILKAP (>>) |
| MMP25 → INVS (>>) |
| MMP25 → KLK5 (>>) |
| MMP25 → LIPG (>>) |
| MMP25 → MAPK7 (>>) |
| MMP25 → MRAS (>>) |
| MMP25 → MYH14 (>>) |
| MMP25 → NFATC1 (>>) |
| MMP25 → PAK2 (>>) |
| MMP25 → PLA2R1 (>>) |
| MMP25 → PRKAA1 (>>) |
| MMP25 → PSORS1C2 (>>) |
| MMP25 → PTMS (>>) |
| MMP25 → RBL2 (>>) |
| MMP25 → SGCA (>>) |
| MMP25 → SMURF1 (>>) |
| MMP25 → SOCS6 (>>) |
| MMP25 → TCEAL1 (>>) |
| MMP25 → UBE2D1 (>>) |
